Scinai Immunotherapeutics Ltd. SCNI US Equity
$2.51
-0.17 (-6.34%)
USD · as of 2026-08-28 · marketstack
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $2.51, -6.3%, on 2026-08-28, with a market cap of $3.7B as of 2026-08-27, a return on equity of -91.9% and a net margin of -633.6%. Institutional ownership, earnings history and filed financials are on the tabs below.
| Date | Event | What happened / filer | Source |
|---|---|---|---|
| 2026-07-09 | 13G/A | Schedule 13G amendment — ≥5% beneficial owner (passive) · by LCK JNK 1 LLC | sec.gov ↗ |
Source: SEC EDGAR (public domain) · history starts 2026-07-09
Every row is a filed document, checked against its EDGAR index.